The approval makes AQVESME the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, a rare blood disorder. The drug is expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback